Your Child Has Cerebral Palsy? Realistic Treatment Options

Every parent of a child with cerebral palsy remembers the day the word first landed. And almost all of them, soon after, meet the same paradox: the therapies the specialists prescribe sound incremental — "widen his range of movement", "improve her tolerance for standing" — while a single search shows clinics promising transformation from cells. The gap between those two worlds is where families get lost, and where savings sometimes disappear. This article is a map of what genuinely helps children with CP, what the cell-therapy research has actually shown, and how to tell the difference.

What cerebral palsy is — and is not

Cerebral palsy is an injury to the developing brain — before, during or shortly after birth — that affects movement and posture. It is not a disease that progresses: the brain injury itself does not worsen over time. But its effects change as a child grows, because a growing body makes new demands on the affected movement. That distinction is everything when evaluating treatments: the injury is permanent, but function, comfort and independence are genuinely improvable — and that improvement is what good treatment pursues.

The therapies with the strongest evidence

• Early intervention and intensive physiotherapy: structured, goal-directed programmes based on the child's own function — the Gross Motor Function Measure is the standard tool — with strong evidence for improving motor skills, especially in younger children.
• Occupational therapy for the daily skills that define independence: feeding, dressing, play, writing.
• Speech and language therapy, including for children who eat or communicate differently because of muscle control.
• Orthoses (bracing and splints) and equipment, which extend what therapy achieves into daily life.
• Botulinum toxin injections for spasticity in specific muscles, combined with physiotherapy — one of the most studied interventions in CP.
• Orthopaedic management of contractures and hip surveillance, and, in carefully selected children with severe spasticity, selective dorsal rhizotomy.
• Epilepsy, feeding and nutrition care when needed — hidden medical problems slow everything else down.

Why researchers studied cord blood for CP

The hypothesis came from laboratory work: umbilical cord blood cells appear to help injured brain tissue partly through the healing signals they release — not by rebuilding the brain, but by supporting its own repair processes. Duke University ran the key early trial: 63 young children with spastic cerebral palsy received an infusion of their own stored cord blood or a placebo, in a blinded crossover design, and were followed with standard motor-function assessments. The headline result was sobering — there was no difference in the average improvement in motor scores between the groups a year later. The interesting finding was a dose signal: children who received higher cell doses showed greater gains than expected for their age and severity. That signal is why research continues, and it is also — critically — not a treatment result. A subgroup signal in a 63-child study is a reason for the next study, not a basis for selling infusions.

Where MSC and other cell approaches stand

Beyond cord blood, small early-phase studies of mesenchymal stromal cell therapy and other cell products have been conducted in cerebral palsy, mostly reporting acceptable safety and occasionally encouraging movement scores — without control groups large or rigorous enough to establish benefit. No cell therapy is approved as a treatment for cerebral palsy in any major regulatory system. For parents, the honest translation is this: the research is legitimate and ongoing, the results so far show safety more than benefit, and a commercial clinic selling transformation is borrowing confidence the trials have not yet earned.

How to judge a clinic's claims for your child

• Ask which published, controlled study supports their exact protocol for cerebral palsy — and read it yourself.
• Ask who the licensed physician responsible for your child is, and what paediatric and neurological expertise sits behind the programme.
• Ask how they will measure change: against what baseline, with which validated scale, over what timeframe.
• Be deeply sceptical of guaranteed outcomes, before-and-after videos presented as typical, and packages priced on urgency.
• Ask what the plan is if nothing improves — and notice whether that question is even entertainable.

The honest bottom line on treatment for cerebral palsy

Cerebral palsy cannot be cured today, and no cell therapy has been shown to change its course. But a child's real life — how far they walk, how clearly they communicate, how independently they manage their day — is genuinely shaped by therapy done early, intensively and consistently, plus excellent medical care of the conditions that travel alongside CP. The cord blood research is worth following honestly, and a registered clinical trial is the right place for any family who wants to contribute to it. Meanwhile, the money and hope that real progress needs are best invested in the therapy hours, equipment and expert care that already have evidence behind them.